Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen refutes 'flawed' cholesterol study
Amgen refutes 'flawed' cholesterol study
Amgen refutes 'flawed' cholesterol study
Submitted by
admin
on August 22, 2016 - 10:06pm
Source:
BioPharma Dive
News Tags:
Amgen
PCSK9 inhibitors
JAMA
Repatha
Headline:
Amgen refutes 'flawed' cholesterol study
Do Not Allow Advertisers to Use My Personal information
